Literature DB >> 8780715

Limited degradation of retinoid X receptor by calpain.

R Matsushima-Nishiwaki1, Y Shidoji, S Nishiwaki, H Moriwaki, Y Muto.   

Abstract

Recently, we have found two major physiological forms of retinoid X receptor alpha (RXR alpha): the mature 54 kDa RXR alpha and the truncated 44 kDa RXR alpha lacking a portion of N-terminal A/B domain in human and rodent livers. In this communication, we show that m-calpain was active to digest 54 kDa RXR alpha in the human hepatoma-derived cell line, HuH7, nuclei to 44 kDa fragment through 47 kDa intermediate in vitro. Although both proteolytic fragments were revealed by anti-RXR alpha antibody against its E-domain, neither fragment reacted with anti-RXR alpha antibody specific for A/B domain. The profile of the calpain-induced proteolytic fragmentation of RXR alpha was almost identical to that endogenous RXR alpha in nonmalignant human and normal mouse liver nuclei. This is the first demonstration that of RXR alpha is a substrate for m-calpain, strongly suggesting that the enzyme might also be involved in post-translational modification of the receptor in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780715     DOI: 10.1006/bbrc.1996.1276

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

2.  Monoclonal antibody 16D10 to the C-terminal domain of the feto-acinar pancreatic protein binds to membrane of human pancreatic tumoral SOJ-6 cells and inhibits the growth of tumor xenografts.

Authors:  Laurence Panicot-Dubois; Muriel Aubert; Cécile Franceschi; Eric Mas; Françoise Silvy; Christian Crotte; Jean-Paul Bernard; Dominique Lombardo; Marie-Odile Sadoulet
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

3.  NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.

Authors:  Hu Zhou; Wen Liu; Ying Su; Zhen Wei; Jie Liu; Siva Kumar Kolluri; Hua Wu; Yu Cao; Jiebo Chen; Yin Wu; Tingdong Yan; Xihua Cao; Weiwei Gao; Andrei Molotkov; Fuquan Jiang; Wen-Gang Li; Bingzhen Lin; Hai-Ping Zhang; Jinghua Yu; Shi-Peng Luo; Jin-Zhang Zeng; Gregg Duester; Pei-Qiang Huang; Xiao-Kun Zhang
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743

Review 4.  Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites.

Authors:  Xiao-kun Zhang; Ying Su; Liqun Chen; Fan Chen; Jie Liu; Hu Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-12-01       Impact factor: 6.150

5.  Regulation of proteolytic cleavage of retinoid X receptor-α by GSK-3β.

Authors:  Weiwei Gao; Jie Liu; Mengjie Hu; Mingfeng Huang; Sisi Cai; Zhiping Zeng; Bingzhen Lin; Xihua Cao; Jiebo Chen; Jin-zhang Zeng; Hu Zhou; Xiao-kun Zhang
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

Review 6.  Targeting truncated RXRα for cancer therapy.

Authors:  Xiaokun Zhang; Hu Zhou; Ying Su
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-21       Impact factor: 3.848

7.  A unique cytoplasmic localization of retinoic acid receptor-gamma and its regulations.

Authors:  Young-Hoon Han; Hu Zhou; Jin-Hee Kim; Ting-dong Yan; Kee-Ho Lee; Hua Wu; Feng Lin; Na Lu; Jie Liu; Jin-zhang Zeng; Xiao-kun Zhang
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

8.  Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.

Authors:  Na Lu; Jinxing Liu; Jie Liu; Chunyun Zhang; Fuquan Jiang; Hua Wu; Liqun Chen; Wenjun Zeng; Xihua Cao; Tingdong Yan; Guanghui Wang; Hu Zhou; Bingzhen Lin; Xiaomei Yan; Xiao-kun Zhang; Jin-Zhang Zeng
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

9.  Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.

Authors:  Liqun Chen; Alexander E Aleshin; Gulimiran Alitongbieke; Yuqi Zhou; Xindao Zhang; Xiaohong Ye; Mengjie Hu; Gaoang Ren; Ziwen Chen; Yue Ma; Duo Zhang; Shuai Liu; Weiwei Gao; Lijun Cai; Lingjuan Wu; Zhiping Zeng; Fuquan Jiang; Jie Liu; Hu Zhou; Gregory Cadwell; Robert C Liddington; Ying Su; Xiao-Kun Zhang
Journal:  Nat Commun       Date:  2017-07-17       Impact factor: 14.919

10.  Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.

Authors:  María E Sáez; Antonio Grilo; Francisco J Morón; Luis Manzano; María T Martínez-Larrad; Antonio González-Pérez; Javier Serrano-Hernando; Agustín Ruiz; Reposo Ramírez-Lorca; Manuel Serrano-Ríos
Journal:  Cardiovasc Diabetol       Date:  2008-07-25       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.